Restoration of Tissue Factor Pathway Inhibitor-2 in a Human Glioblastoma Cell Line Triggers Caspase-Mediated Pathway and Apoptosis
- 15 June 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (12), 3507-3517
- https://doi.org/10.1158/1078-0432.ccr-06-3023
Abstract
Purpose: The induction of apoptotic pathways in cancer cells offers a novel and potentially useful approach to improve patient responses to conventional chemotherapy. Tissue factor pathway inhibitor-2 (TFPI-2) is a protease inhibitor that is abundant in the extracellular matrix and highly expressed in noninvasive cells but absent or undetectable in highly invasive human glioblastoma cells. Experimental Design: Using a recombinant adeno-associated viral vector carrying human TFPI-2 cDNA, we stably expressed TFPI-2 in U-251 cells, a highly invasive human glioblastoma cell line. Our previous studies showed that restoration of TFPI-2 in glioblastomas effectively prevents cell proliferation, angiogenesis, and tumor invasion. In this study, we determined whether TFPI-2 restoration could induce apoptosis through the caspase-mediated signaling pathway. Results: The results from nuclear chromatin staining, terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling assay, and fluorescence-activated cell sorting analysis showed increased apoptosis in U-251 cells after restoration of TFPI-2. Caspase-9 and caspase-3 activity assays showed increased activity, indicating enhanced apoptosis. Immunofluorescence for cleaved caspase-9 and caspase-3 depicted increased expression and colocalization of both molecules. Western blot analysis showed increased transcriptional activities of Fas ligand, tumor necrosis factor-α, Bax, Fas-associated death domain, and tumor necrosis factor receptor 1–associated death domain as well as elevated levels of cleaved caspases and poly(ADP-ribose) polymerase. Semiquantitative reverse transcription-PCR depicted increased expression of tumor necrosis factor-α and Fas ligand and the related death domains tumor necrosis factor receptor 1–associated death domain and Fas-associated death domain. Conclusions: Taken together, these results show that restoration of TFPI-2 activates both intrinsic and extrinsic caspase-mediated, proapoptotic signaling pathways and induces apoptosis in U-251 cells. Furthermore, our study suggests that recombinant adeno-associated viral vector–mediated gene expression offers a novel tool for cancer gene therapy.Keywords
This publication has 42 references indexed in Scilit:
- CD95L/FasL and TRAIL in Tumour Surveillance and Cancer TherapyPublished by Springer Science and Business Media LLC ,2006
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Cytotoxicity of cytokines in cerebral microvascular endothelial cellBrain Research, 2003
- cDNA macroarray analysis of gene expression in synoviocytes stimulated with TNFαFEBS Letters, 2002
- Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatmentOncogene, 2002
- A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasionOncogene, 2001
- Matrix metalloproteinases: they're not just for matrix anymore!Current Opinion in Cell Biology, 2001
- Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosisJCI Insight, 2001
- The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastomaEuropean Journal Of Cancer, 2001
- Apoptosis SignalingAnnual Review of Biochemistry, 2000